Global Infectious Disease Diagnostic Market, Opportunity Analysis, Market Shares and Forecast, 2017 - 2023

  • ID: 3976023
  • Report
  • Region: Global
  • 140 pages
  • Occams Business Research and Consulting
1 of 4
The Global Infectious Disease Diagnostic Market is Estimated to Grow at CAGR 8.2% During Period 2016-2022.

FEATURED COMPANIES

  • Abbott Laboratories
  • Auritec Pharmaceuticals
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Pfizer
  • MORE

The global infectious disease diagnostic market is estimated to grow at CAGR 8.2% during period 2016-2022. The market is estimated to reach $18.3billion by 2022. Increasing in prevalence of infectious diseases, growing personalized medicine, Aging population and increasing in healthcare expenditure are driving infectious disease diagnostic market for the forecasted period. An Aging World: 2015, a report by national Institute of Health projects world’s geriatric population aged 65 and over to be 8.5% in 2015. The report predicts geriatric population to reach around 17% by 2050. Chance of getting infections (around 33%) among elderly population aged 65 years and above is higher with progression of age due to weakening immune systems. Urinary tract infections, skin infections and influenza are the leading infectious diseases observed among geriatric population. Age is the major factor for developing cancer. Almost 60% of all population aged 65 and above have cancer.

The research report is segmented as, techniques, applications and end users. Application segment is further classified as Tuberculosis, Human Papillomavirus, Methicillin-Resistant Staphylococcus aureus, AIDS, Trachomatis & Neisseria, hepatitis B, hepatitis C and other applications. The largest market share of 25% in 2015 was for Tuberculosis (TB) diagnostic kit. TB is one of the leading causes of mortality in the world. According to WHO, over 10.8million per year worldwide get sick with TB. The mortality rates of TB grew from 1.5million in 2014 to 1.85million in 2016. Late detection and growing resistance to medications are factors leading to increased mortality of TB. Asia Pacific and Africa have high prevalence rates of TB (61% and 26% new cases in 2015). India, China, Nigeria, South Africa, have high prevalence, making them lucrative markets for TB diagnostic kit for the forecasted period.

Lack of skilled personnel to conduct diagnostics tests, loop holes in reimbursement policies, rising healthcare cost, increasing competition, and complex regulatory compliance framework delaying product launch are the challenges deliberated in the research report.

The research report evaluated infectious diseases diagnostic market geographically. Region wise the report is classified into North America, Europe, Asia Pacific, and Rest of the World. North America is the leading infectious disease diagnostic market. North America had market share of over 37% in 2015. North America is followed by Europe. Infectious disease diagnostic market share for Europe in 2015 was 30%. High quality healthcare infrastructure, increasing investments in research & development and high income disposable population are the dynamics driving the market in North America and Europe for the forecasted period. Both, Asia Pacific and Africa are the fastest growing market. Asia Pacific is estimated to grow 13% CAGR for the forecasted period.

Johnson & Johnson Ltd., Merck & Co., Pfizer Inc., Hoffmann-La Roche., GlaxoSmithKline Pharmaceuticals Ltd., are some of the top companies in infectious disease diagnostic market. The report segmented infectious disease diagnostic market on the basis of applications, products, techniques, and end users. The USP of our report is the country level analysis of each geographical region. The research report gives revenue of top five companies in the market, demand of infectious disease diagnostics from end user industries and price of diagnostic kits. The data is gathered via primary and secondary research. The report provides detailed analysis of key market players and their strategies.



Note:
Please allow up to 72 hours for delivery.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • Auritec Pharmaceuticals
  • Bio-Rad Laboratories
  • F. Hoffmann-La Roche
  • Johnson & Johnson
  • Pfizer
  • MORE

1. Introduction
1.1. Executive Summary
1.2. Market Scope

2. Market Overview
2.1. Global Infectious Disease Diagnostic Market: Evolution & Transition
2.2. Industry Structure
2.3. Manufacturing Process
2.4. Regulatory Framework
2.5. Total Market Analysis
2.5.1. Top 5 Findings
2.5.2. Top 5 Opportunity Markets
2.5.3. Top 5 Companies
2.5.4. Top 3 Competitive Strategies
2.6. Estimation Analysis
2.6.1. Share of Acoustic Insulation in Global Insulation Market
2.6.2. Demand of Acoustic Insulation in Building & Construction Industry
2.6.3. Revenue of Top 5 Market Players
2.7. Strategic Analysis
2.7.1. Investment Vs. Adoption Model
2.7.2. 360 Degree Industry Analysis
2.7.3. Porters 5 Force Model
2.7.4. See-Saw Analysis
2.7.5. Pricing Analysis
2.7.6. Consumer Analysis And Key Buying Criteria
2.7.7. Roi Analysis
2.7.8. Gap Analysis
2.8. Competitive Analysis
2.8.1. Key Strategies And Analysis
2.8.2. Market Share
2.8.3. Top Company Analysis
2.9. Strategic Recommendations & Key Conclusions
2.9.1. Investment Opportunities By Regions
2.9.2. Opportunities in Emerging Applications
2.9.3. Investment Opportunity in Fastest Growing Segment

3. Market Determinants
3.1. Market Drivers & Market Impact
3.1.1. Increasing Prevalence of Infectious Diseases
3.1.2. Increasing Health Care Expenditure
3.1.3. Aging Population
3.1.4. Rising Awareness About Communicable Disease Among People
3.1.5. Growing Demand for Personalized Medicine
3.2. Market Restraints & Market Impact
3.2.1. Complex Regulatory Compliance Framework Delaying Product Launch
3.2.2. Rising Healthcare Cost
3.2.3. Increasing Competition
3.3. Market Opportunities
3.3.1. Emerging Economies
3.3.2. New Innovations in Diagnostics
3.3.3. Changing Healthcare Reforms
3.4. Market Challenges
3.4.1. Lack of Skilled Personnel to Conduct Diagnostic Tests
3.4.2. Loop Holes in Reimbursement Policies

4. Market Segmentation
4.1. Global Infectious Disease Diagnostic Market By Product 2014-2022 ($ Million)
4.1.1. Market Definition And Scope
4.1.2. Decision Support Database & Estimation Methodology
4.1.3. Comparative Analysis Across Market Segments
4.1.4. Opportunity Matrix
4.1.5. Market Segmentation
4.1.5.1. Instruments & Analyzers 2014-2022 ($ Million)
4.1.5.1.1. Applications
4.1.5.1.2. Adoption Scenario & Market Determinants
4.1.5.1.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.1.5.1.4. Top Players & Key Products
4.1.5.1.5. Key Conclusions
4.1.5.2. Consumables 2014-2022 ($ Million)
4.1.5.2.1. Applications
4.1.5.2.2. Adoption Scenario & Market Determinants
4.1.5.2.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.1.5.2.4. Top Players & Key Products
4.1.5.2.5. Key Conclusions
4.1.5.2.6. Consumables By Sub Segmentation
4.1.5.2.6.1. Assay & Reagents
4.1.5.3. Services & Software 2014-2022 ($ Million)
4.1.5.3.1. Applications
4.1.5.3.2. Adoption Scenario & Market Determinants
4.1.5.3.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.1.5.3.4. Top Players & Key Products
4.1.5.3.5. Key Conclusions
4.2. Global Infectious Disease Diagnostic Market By Application 2014-2022 ($ Million)
4.2.1. Market Definition And Scope
4.2.2. Decision Support Database & Estimation Methodology
4.2.3. Comparative Analysis Across Market Segments
4.2.4. Opportunity Matrix
4.2.5. Market Segmentation
4.2.5.1. Hepatitis B 2014-2022 ($ Million)
4.2.5.1.1. Applications
4.2.5.1.2. Adoption Scenario & Market Determinants
4.2.5.1.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.1.3.1. Market Revenues 2014-2022 ($ Million)
4.2.5.1.4. Top Players & Key Products
4.2.5.1.5. Key Conclusions
4.2.5.2. Hepatitis C 2014-2022 ($ Million)
4.2.5.2.1. Applications
4.2.5.2.2. Adoption Scenario & Market Determinants
4.2.5.2.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.2.4. Top Players & Key Products
4.2.5.2.5. Key Conclusions
4.2.5.3. Aids 2014-2022 ($ Million)
4.2.5.3.1. Applications
4.2.5.3.2. Adoption Scenario & Market Determinants
4.2.5.3.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.3.4. Top Players & Key Products
4.2.5.3.5. Key Conclusions
4.2.5.4. Tuberculosis 2014-2022 ($ Million)
4.2.5.4.1. Applications
4.2.5.4.2. Adoption Scenario & Market Determinants
4.2.5.4.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.4.4. Top Players & Key Products
4.2.5.4.5. Key Conclusions
4.2.5.5. Chlamydia Trachomatis & Neisseria Gonorrhoeae (Ct/Ng) 2014-2022 ($ Million)
4.2.5.5.1. Applications
4.2.5.5.2. Adoption Scenario & Market Determinants
4.2.5.5.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.5.4. Top Players & Key Products
4.2.5.5.5. Key Conclusions
4.2.5.6. Human Papillomavirus (Hpv) 2014-2022 ($ Million)
4.2.5.6.1. Applications
4.2.5.6.2. Adoption Scenario & Market Determinants
4.2.5.6.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.6.4. Top Players & Key Products
4.2.5.6.5. Key Conclusions
4.2.5.7. Methicillin-Resistant Staphylococcus Aureus (Mrsa) 2014-2022 ($ Million)
4.2.5.7.1. Applications
4.2.5.7.2. Adoption Scenario & Market Determinants
4.2.5.7.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.7.4. Top Players & Key Products
4.2.5.7.5. Key Conclusions
4.2.5.8. Other Applications (Influenza, Ebola, Typhoid, Malaria) 2014-2022 ($ Million)
4.2.5.8.1. Applications
4.2.5.8.2. Adoption Scenario & Market Determinants
4.2.5.8.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.2.5.8.4. Top Players & Key Products
4.2.5.8.5. Key Conclusions
4.3. Global Infectious Disease Diagnostic Market By Technique 2014-2022 ($ Million)
4.3.1. Market Definition And Scope
4.3.2. Decision Support Database & Estimation Methodology
4.3.3. Comparative Analysis Across Market Segments
4.3.4. Opportunity Matrix
4.3.5. Market Segmentation
4.3.5.1. Traditional Diagnostic Techniques
4.3.5.1.1. Applications
4.3.5.1.2. Adoption Scenario & Market Determinants
4.3.5.1.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.3.5.1.4. Top Players & Key Products
4.3.5.1.5. Key Conclusions
4.3.5.1.6. Traditional Diagnostic Techniques By Sub Segment
4.3.5.1.6.1. Microscopy
4.3.5.1.6.2. Immunodiagnostics
4.3.5.1.6.3. Biochemical Characterization
4.3.5.2. Molecular Diagnostics
4.3.5.2.1. Applications
4.3.5.2.2. Adoption Scenario & Market Determinants
4.3.5.2.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.3.5.2.4. Top Players & Key Products
4.3.5.2.5. Key Conclusions
4.4. Global Infectious Disease Diagnostic Market By End User 2014-2022 ($ Million)
4.4.1. Market Definition And Scope
4.4.2. Decision Support Database & Estimation Methodology
4.4.3. Comparative Analysis Across Market Segments
4.4.4. Opportunity Matrix
4.4.5. Market Segmentation
4.4.5.1. Hospital Reference Labs
4.4.5.1.1. Applications
4.4.5.1.2. Adoption Scenario & Market Determinants
4.4.5.1.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.4.5.1.4. Top Players & Key Products
4.4.5.1.5. Key Conclusions
4.4.5.2. Institutions Or Academics
4.4.5.2.1. Applications
4.4.5.2.2. Adoption Scenario & Market Determinants
4.4.5.2.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.4.5.2.4. Top Players & Key Products
4.4.5.2.5. Key Conclusions
4.4.5.3. Others End Users (Blood Banks, Local Public Health Laboratories)
4.4.5.3.1. Applications
4.4.5.3.2. Adoption Scenario & Market Determinants
4.4.5.3.3. Market Estimations And Forecasts 2014-2022 ($ Million)
4.4.5.3.4. Top Players & Key Products
4.4.5.3.5. Key Conclusions

5. Competitive Landscape
5.1. Key Strategies
5.1.1. List of M&A
5.1.2. List of Jv
5.1.3. List of Product Launches
5.1.4. List of Partnership
5.2. Top 10 Company Analysis - Dashboard

6. Global Infectious Disease Diagnostic Market By Region (Revenue Analysis) 2014-2022 ($ Million)
6.1. Decision Support Database & Estimation Methodology
6.2. Comparative Analysis Across Market Segments
6.3. Opportunity Matrix
6.4. Geographic Segmentation
6.4.1. North America
6.4.1.1. Industry Application Analysis
6.4.1.2. Top Country Analysis
6.4.1.2.1. U.S.
6.4.1.2.1.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.1.2.1.2. Market Revenues 2014-2022 ($ Million)
6.4.1.2.1.3. Price Analysis
6.4.1.2.1.4. Top Players & Key Products
6.4.1.2.1.5. Key Conclusions
6.4.1.2.2. Canada
6.4.1.2.2.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.1.2.2.2. Market Revenues 2014-2022 ($ Million)
6.4.1.2.2.3. Price Analysis
6.4.1.2.2.4. Top Players & Key Products
6.4.1.2.2.5. Key Conclusions
6.4.2. Europe
6.4.2.1. Industry Application Analysis
6.4.2.2. Top Country Analysis
6.4.2.2.1. Uk
6.4.2.2.1.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.1.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.1.3. Price Analysis
6.4.2.2.1.4. Top Players & Key Products
6.4.2.2.1.5. Key Conclusions
6.4.2.2.2. France
6.4.2.2.2.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.2.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.2.3. Price Analysis
6.4.2.2.2.4. Top Players & Key Products
6.4.2.2.2.5. Key Conclusions
6.4.2.2.3. Germany
6.4.2.2.3.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.3.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.3.3. Price Analysis
6.4.2.2.3.4. Top Players & Key Products
6.4.2.2.3.5. Key Conclusions
6.4.2.2.4. Spain
6.4.2.2.4.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.4.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.4.3. Price Analysis
6.4.2.2.4.4. Top Players & Key Products
6.4.2.2.4.5. Key Conclusions
6.4.2.2.5. Italy
6.4.2.2.5.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.5.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.5.3. Price Analysis
6.4.2.2.5.4. Top Players & Key Products
6.4.2.2.5.5. Key Conclusions
6.4.2.2.6. Rest of Europe
6.4.2.2.6.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.2.2.6.2. Market Revenues 2014-2022 ($ Million)
6.4.2.2.6.3. Price Analysis
6.4.2.2.6.4. Top Players & Key Products
6.4.2.2.6.5. Key Conclusions
6.4.3. Asia Pacific
6.4.3.1. Industry Application Analysis
6.4.3.2. Top Country Analysis
6.4.3.2.1. China
6.4.3.2.1.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.1.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.1.3. Price Analysis
6.4.3.2.1.4. Top Players & Key Products
6.4.3.2.1.5. Key Conclusions
6.4.3.2.2. India
6.4.3.2.2.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.2.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.2.3. Price Analysis
6.4.3.2.2.4. Top Players & Key Products
6.4.3.2.2.5. Key Conclusions
6.4.3.2.3. Japan
6.4.3.2.3.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.3.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.3.3. Price Analysis
6.4.3.2.3.4. Top Players & Key Products
6.4.3.2.3.5. Key Conclusions
6.4.3.2.4. South Korea
6.4.3.2.4.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.4.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.4.3. Price Analysis
6.4.3.2.4.4. Top Players & Key Products
6.4.3.2.4.5. Key Conclusions
6.4.3.2.5. Australia
6.4.3.2.5.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.5.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.5.3. Price Analysis
6.4.3.2.5.4. Top Players & Key Products
6.4.3.2.5.5. Key Conclusions
6.4.3.2.6. Rest of Asia Pacific
6.4.3.2.6.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.3.2.6.2. Market Revenues 2014-2022 ($ Million)
6.4.3.2.6.3. Price Analysis
6.4.3.2.6.4. Top Players & Key Products
6.4.3.2.6.5. Key Conclusions
6.4.4. Row
6.4.4.1. Industry Application Analysis
6.4.4.2. Top Country Analysis
6.4.4.2.1. Latin America
6.4.4.2.1.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.4.2.1.2. Market Revenues 2014-2022 ($ Million)
6.4.4.2.1.3. Price Analysis
6.4.4.2.1.4. Top Players & Key Products
6.4.4.2.1.5. Key Conclusions
6.4.4.2.2. Middle East & Africa
6.4.4.2.2.1. Market Estimations And Forecasts 2014-2022 ($ Million)
6.4.4.2.2.2. Market Revenues 2014-2022 ($ Million)
6.4.4.2.2.3. Price Analysis
6.4.4.2.2.4. Top Players & Key Products
6.4.4.2.2.5. Key Conclusions

7. Company Profiles
7.1. Johnson & Johnson
7.1.1. Overview
7.1.2. Product Portfolio
7.1.3. Key Innovation Sector
7.1.4. Strategic Initiatives
7.1.5. Scot Analysis
7.2. Merck & Co
7.2.1. Overview
7.2.2. Product Portfolio
7.2.3. Key Innovation Sector
7.2.4. Strategic Initiatives
7.2.5. Scot Analysis
7.3. Pfizer
7.3.1. Overview
7.3.2. Product Portfolio
7.3.3. Key Innovation Sector
7.3.4. Strategic Initiatives
7.3.5. Scot Analysis
7.4. F. Hoffmann-La Roche
7.4.1. Overview
7.4.2. Product Portfolio
7.4.3. Key Innovation Sector
7.4.4. Strategic Initiatives
7.4.5. Scot Analysis
7.5. Glasxosmithkline Pharmaceutical Inc.,
7.5.1. Overview
7.5.2. Product Portfolio
7.5.3. Key Innovation Sector
7.5.4. Strategic Initiatives
7.5.5. Scot Analysis
7.6. Auritec Pharmaceuticals
7.6.1. Overview
7.6.2. Product Portfolio
7.6.3. Key Innovation Sector
7.6.4. Strategic Initiatives
7.6.5. Scot Analysis
7.7. Abbott Laboratories
7.7.1. Overview
7.7.2. Product Portfolio
7.7.3. Key Innovation Sector
7.7.4. Strategic Initiatives
7.7.5. Scot Analysis
7.8. Alere
7.8.1. Overview
7.8.2. Product Portfolio
7.8.3. Key Innovation Sector
7.8.4. Strategic Initiatives
7.8.5. Scot Analysis
7.9. Gen-Probe Inc.,
7.9.1. Overview
7.9.2. Product Portfolio
7.9.3. Key Innovation Sector
7.9.4. Strategic Initiatives
7.9.5. Scot Analysis
7.10. Becton Dickinson Company Inc.,
7.10.1. Overview
7.10.2. Product Portfolio
7.10.3. Key Innovation Sector
7.10.4. Strategic Initiatives
7.10.5. Scot Analysis
7.11. Bio-Rad Laboratories
7.11.1. Overview
7.11.2. Product Portfolio
7.11.3. Key Innovation Sector
7.11.4. Strategic Initiatives
7.11.5. Scot Analysis
7.12. Siemens Healthcare
7.12.1. Overview
7.12.2. Product Portfolio
7.12.3. Key Innovation Sector
7.12.4. Strategic Initiatives
7.12.5. Scot Analysis
7.13. Biomeriux Sa
7.13.1. Overview
7.13.2. Product Portfolio
7.13.3. Key Innovation Sector
7.13.4. Strategic Initiatives
7.13.5. Scot Analysis
7.14. Danaher Corporation
7.14.1. Overview
7.14.2. Product Portfolio
7.14.3. Key Innovation Sector
7.14.4. Strategic Initiatives
7.14.5. Scot Analysis
7.15. Thermo Fisher Scientific Inc.,
7.15.1. Overview
7.15.2. Product Portfolio
7.15.3. Key Innovation Sector
7.15.4. Strategic Initiatives
7.15.5. Scot Analysis

List of Tables:
1. Global Infectious Disease Diagnostic Market By Product 2014-2022 ($ Million)
2. Global Instruments & Analyzers By Geography 2014-2022 ($ Million)
3. Global Consumables By Geography 2014-2022 ($ Million)
4. Global Assay & Reagents Market By Geography 2014-2022 ($ Million)
5. Global Services & Software Market By Geography 2014-2022 ($ Million)
6. Global Infectious Disease Diagnostic Market By Application 2014-2022 ($ Million)
7. Global Hepatitis B Market By Geography 2014-2022 ($ Million)
8. Global Hepatitis C Market By Geography 2014-2022 ($ Million)
9. Global Aids Market By Geography 2014-2022 ($ Million)
10. Global Tuberculosis Market By Geography 2014-2022 ($ Million)
11. Global Chlamydia Trachomatis & Neisseria Gonorrhoeae (Ct/Ng) Market By Geography 2014-2022 ($ Million)
12. Global Human Papillomavirus (Hpv) Market By Geography 2014-2022 ($ Million)
13. Global Methicillin-Resistant Staphylococcus Aureus (Mrsa) Market By Geography 2014-2022 ($ Million)
14. Global Other Applications (Influenza, Ebola, Typhoid, Malaria) Market By Geography 2014-2022 ($ Million)
15. Global Infectious Disease Diagnostic Market By Techniques 2014-2022 ($ Million)
16. Global Traditional Diagnostic Techniques Market By Geography 2014-2022 ($ Million)
17. Global Molecular Diagnostic Techniques Market By Geography 2014-2022 ($ Million)
18. Global Infectious Disease Diagnostic Market By End User 2014-2022 ($ Million)
19. Global Infectious Disease Diagnostic Market in Hospital Reference Labs By Geography 2014-2022 ($ Million)
20. Global Infectious Disease Diagnostic Market in Institutions Or Academics By Geography 2014-2022 ($ Million)
21. Global Infectious Disease Diagnostic Market in Other End Users By Geography 2014-2022 ($ Million)
22. North America Infectious Disease Diagnostic Market 2014-2022 ($ Million)
23. Europe Infectious Disease Diagnostic Market 2014-2022 ($ Million)
24. Asia Pacific Infectious Disease Diagnostic Market 2014-2022 ($ Million)
25. Rest of the World Infectious Disease Diagnostic Market 2014-2022 ($ Million)

List of Figures:
1. Global Infectious Disease Diagnostic Market By Instruments & Analyzers 2014-2022 ($ Million)
2. Global Infectious Disease Diagnostic Market By Consumables 2014-2022 ($ Million)
3. Global Infectious Disease Diagnostic Market By Assay & Reagents 2014-2022 ($ Million)
4. Global Infectious Disease Diagnostic Market By Aerogel And Cellulose 2014-2022 ($ Million)
5. Global Infectious Disease Diagnostic Market By Services & Software 2014-2022 ($ Million)
6. Global Infectious Disease Diagnostic Market By Hepatitis B 2014-2022 ($ Million)
7. Global Infectious Disease Diagnostic Market By Hepatitis C 2014-2022 ($ Million)
8. Global Infectious Disease Diagnostic Market By Aids 2014-2022 ($ Million)
9. Global Infectious Disease Diagnostic Market By Tuberculosis 2014-2022 ($ Million)
10. Global Infectious Disease Diagnostic Market By Chlamydia Trachomatis & Neisseria Gonorrhoeae (Ct/Ng) 2014-2022 ($ Million)
11. Global Infectious Disease Diagnostic Market By Human Papillomavirus (Hpv) 2014-2022 ($ Million)
12. Global Infectious Disease Diagnostic Market By Methicillin-Resistant Staphylococcus Aureus (Mrsa) 2014-2022 ($ Million)
13. Global Infectious Disease Diagnostic Market By Other Applications (Influenza, Ebola, Typhoid, Malaria) 2014-2022 ($ Million)
14. Global Infectious Disease Diagnostic Market By Traditional Diagnostic Techniques 2014-2022 ($ Million)
15. Global Infectious Disease Diagnostic Market By Molecular Diagnostic Techniques 2014-2022 ($ Million)
16. Global Infectious Disease Diagnostic Market By Hospital Reference Labs 2014-2022 ($ Million)
17. Global Infectious Disease Diagnostic Market By Institutions Or Academics 2014-2022 ($ Million)
18. Global Infectious Disease Diagnostic Market By Other End Users 2014-2022 ($ Million)
19. United States (U.S.) Infectious Disease Diagnostic Market 2014-2022 ($ Million)
20. Canada Infectious Disease Diagnostic Market 2014-2022 ($ Million)
21. United Kingdom (Uk) Infectious Disease Diagnostic Market 2014-2022 ($ Million)
22. France Infectious Disease Diagnostic Market 2014-2022 ($ Million)
23. Germany Infectious Disease Diagnostic Market 2014-2022 ($ Million)
24. Spain Infectious Disease Diagnostic Market 2014-2022 ($ Million)
25. Italy Infectious Disease Diagnostic Market 2014-2022 ($ Million)
26. Roe Infectious Disease Diagnostic Market 2014-2022 ($ Million)
27. India Infectious Disease Diagnostic Market 2014-2022 ($ Million)
28. China Infectious Disease Diagnostic Market 2014-2022 ($ Million)
29. Japan Infectious Disease Diagnostic Market 2014-2022 ($ Million)
30. Korea Infectious Disease Diagnostic Market 2014-2022 ($ Million)
31. Australia Infectious Disease Diagnostic Market 2014-2022 ($ Million)
32. Roapac Infectious Disease Diagnostic Market 2014-2022 ($ Million)
33. Latin America Infectious Disease Diagnostic Market 2014-2022 ($ Million)
34. Mena Infectious Disease Diagnostic Market 2014-2022 ($ Million)
35. Africa Infectious Disease Diagnostic Market 2014-2022 ($ Million)

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • Alere
  • Auritec Pharmaceuticals
  • Becton Dickinson Company Inc.,
  • Bio-Rad Laboratories
  • Biomeriux Sa
  • Danaher Corporation
  • F. Hoffmann-La Roche
  • Gen-Probe Inc.,
  • Glasxosmithkline Pharmaceutical Inc.,
  • Johnson & Johnson
  • Merck & Co
  • Pfizer
  • Siemens Healthcare
  • Thermo Fisher Scientific Inc.,
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll